about
Proteasome inhibitor MG132 induces apoptosis and inhibits invasion of human malignant pleural mesothelioma cellsCaveolin-1 regulates Mcl-1 stability and anoikis in lung carcinoma cellsmir-29 regulates Mcl-1 protein expression and apoptosisStapled BH3 peptides against MCL-1: mechanism and design using atomistic simulationsPosttranscriptional regulation of cancer traits by HuRNaturally Occurring Isothiocyanates Exert Anticancer Effects by Inhibiting Deubiquitinating EnzymesEarly apoptosis of porcine alveolar macrophages limits avian influenza virus replication and pro-inflammatory dysregulation.Modulation of Mcl-1 expression reduces age-related cochlear degenerationSpindle poisons and cell fate: a tale of two pathways.Regulation of protein stability by GSK3 mediated phosphorylation.Transcriptional networks in plasmacytoid dendritic cells stimulated with synthetic TLR 7 agonistsGene expression patterns in myelodyplasia underline the role of apoptosis and differentiation in disease initiation and progression.BAG1: the guardian of anti-apoptotic proteins in acute myeloid leukemia.Stat5 regulates cellular iron uptake of erythroid cells via IRP-2 and TfR-1.ATL9, a RING zinc finger protein with E3 ubiquitin ligase activity implicated in chitin- and NADPH oxidase-mediated defense responsesThe downregulation of Mcl-1 via USP9X inhibition sensitizes solid tumors to Bcl-xl inhibition.Translational repression of MCL-1 couples stress-induced eIF2 alpha phosphorylation to mitochondrial apoptosis initiation.Paclitaxel-induced apoptosis is BAK-dependent, but BAX and BIM-independent in breast tumor.Hepatitis B virus X protein enhances cisplatin-induced hepatotoxicity via a mechanism involving degradation of Mcl-1.The duration of gastrin treatment affects global gene expression and molecular responses involved in ER stress and anti-apoptosis.HBx sensitizes cells to oxidative stress-induced apoptosis by accelerating the loss of Mcl-1 protein via caspase-3 cascadeAnti-apoptotic role of HIF-1 and AP-1 in paclitaxel exposed breast cancer cells under hypoxiaTriptolide induces apoptotic cell death of human cholangiocarcinoma cells through inhibition of myeloid cell leukemia-1.Mechanism by which Mcl-1 regulates cancer-specific apoptosis triggered by mda-7/IL-24, an IL-10-related cytokineEnhanced expression of cohesin loading factor NIPBL confers poor prognosis and chemotherapy resistance in non-small cell lung cancerTranscription inhibition by flavopiridol: mechanism of chronic lymphocytic leukemia cell death.Degradation of Mcl-1 by beta-TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitizationGlycogen Synthase Kinase-3β and Caspase-2 Mediate Ceramide- and Etoposide-Induced Apoptosis by Regulating the Lysosomal-Mitochondrial Axis.MYCN repression of Lifeguard/FAIM2 enhances neuroblastoma aggressivenessBodyguards and assassins: Bcl-2 family proteins and apoptosis control in chronic lymphocytic leukaemia.Prazosin displays anticancer activity against human prostate cancers: targeting DNA and cell cycleThe protein kinase C delta catalytic fragment targets Mcl-1 for degradation to trigger apoptosis.The antiapoptotic role of pregnane X receptor in human colon cancer cells.Myeloid cell leukemia-1 as a therapeutic target.Apoptotic effect of hot water extract of Sanguisorba officinalis L. in human oral cancer cells.Gastrin increases mcl-1 expression in type I gastric carcinoid tumors and a gastric epithelial cell line that expresses the CCK-2 receptor.PI3K-dependent upregulation of Mcl-1 by human cytomegalovirus is mediated by epidermal growth factor receptor and inhibits apoptosis in short-lived monocytes.Expanding circle of inhibition: small-molecule inhibitors of Bcl-2 as anticancer cell and antiangiogenic agents.Down-regulation of myeloid cell leukemia-1 through inhibiting Erk/Pin 1 pathway by sorafenib facilitates chemosensitization in breast cancer.The role of biglycan in the heart.
P2860
Q24170504-FED211F1-1CF1-4D28-B8D0-24E899E5D8DFQ24303545-0CD62349-B1B6-4A6F-B36A-5CB6A86EF3DDQ24652606-17ED9E3B-B7E0-4005-A3A6-7E2C2BE0C664Q27321588-DA881F8E-9A2E-4FAA-A082-32CA8B9A5135Q28248667-A499D9D4-10CA-47BE-84C4-8E0FD6DF0D8FQ28269486-B1F2191B-0326-4E50-AF16-9DCEA55139D0Q30382251-E94DF5AE-9C7C-4420-B4C0-FA8DEED067B1Q30427260-55C1F686-ECB6-4A12-A3C9-0B4338ABF376Q30431071-5BEC550C-CB98-4367-9611-12231C574366Q30437017-C7A5F6AC-2B7E-4E81-B229-F40DFAD0BC33Q33302568-5F4A33A1-C8AF-4BE5-8E84-9730A109DDE8Q33788954-EE49DFF3-EA08-414A-811D-2D5775614A02Q34053504-5F3D9B5C-6B6A-489A-83EC-0869C1B8BCE9Q34293299-D3F0E267-3189-4A3D-9B05-7D08FBE303D5Q34437829-BA125378-2669-43AF-A9F3-5782CA67995DQ34484344-F67CF1EB-91E5-48A6-BDFF-68DE9141C418Q34635166-44BD69C4-C99B-4EA5-9ECF-5A784A4FA1A8Q34663927-281BD503-7C4A-4B37-926F-BF6CFA5AB228Q34742600-9B95FC79-6C21-4941-A6EB-48AA4B3D077EQ34785870-D283672C-3C80-4901-8204-0432B0CB483CQ34987519-FD0EF60F-45B1-4B97-9ED6-7EE90A7C81D0Q34992476-B43C1548-FFE4-4A7E-B69A-11474C117B54Q35151115-0CCF83EE-02F1-4317-B833-491B53239894Q35209685-F7438CB4-0CDD-4374-BE16-28DCFD83988AQ35627061-DB6C6067-BE1A-456F-A414-D8D9DE0FE033Q35848241-406FA53E-06E1-4C50-8449-4715BED80BA3Q35857019-8B756EFA-3DBF-46EF-974D-9998D9D111B4Q35884004-F7C1D378-7D3F-4C68-9CA2-2E1482CE35C2Q35966204-5E76BF3D-339D-4176-B91D-B8B76225B069Q36085962-B3121BB6-8186-4A33-AFE1-1CF663288EDCQ36088641-40408A1A-9F26-460D-A0B5-1A4661DB36B1Q36391071-4D5FA81B-5333-4654-A31C-0C7267269B1DQ36512415-843B2221-B0A2-4E1F-BFC3-3BCE0EE755E9Q36734942-FF2C9AE4-8AB2-4623-B70D-8CBD04CAAE40Q36905328-A16EF50F-B6B6-4C69-BB46-30EBC4BAD263Q36956089-33977B45-02B2-42BD-8F06-369E17DD4078Q37095286-7226B84F-0AF1-4A01-977A-ACC0545FEFF3Q37124747-59121D04-A913-4095-8A2D-53F1BF7CA7DAQ37177949-C40DF667-E62F-489C-BCE2-3A5A3D4A9767Q37228517-58787A0A-82F9-42E6-9F7D-564BFB02F6A7
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Mcl-1.
@ast
Mcl-1.
@en
type
label
Mcl-1.
@ast
Mcl-1.
@en
prefLabel
Mcl-1.
@ast
Mcl-1.
@en
P1476
Mcl-1
@en
P2093
Jorg Michels
Peter W M Johnson
P304
P356
10.1016/J.BIOCEL.2004.04.007
P577
2005-02-01T00:00:00Z